Semma goes on a successful ‘fishing’ expedition in its hunt for a diabetes cure
Semma Therapeutics is reporting some key progress in its complex pursuit of a cure for Type 1 diabetes.
In a new study published in Nature, researchers at Harvard and the biotech say they’ve made a major leap in their ability to transform stem cells into a high concentration of insulin-producing beta cells. Starting out at 30% purity, they’ve upped their average to 80%, opening the door wider to a brand new therapeutic approach.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.